Скачать с ютуб Exciting Myeloma Treatments in 2023: Longer Remissions and Better Outcomes! | The Patient Story в хорошем качестве

Exciting Myeloma Treatments in 2023: Longer Remissions and Better Outcomes! | The Patient Story

Multiple myeloma patient advocate Jack Aiello has been living with myeloma for 28 years. When he was diagnosed, he was told he would only have 2 to 3 years to live and there were only 2 treatment options available. Jack underwent 2 transplants and a clinical trial but nothing worked until a third transplant. In this conversation, he speaks with Alfred Garfall MD, a myeloma specialist at Penn Medicine. They discuss the advancement of immunotherapy for multiple myeloma, the difference between CAR T-cell therapy and bispecific antibodies and when these exciting, new treatments will be available to most patients. Full story & transcript → https://www.thepatientstory.com/medic... Thank you to Janssen for its support of our patient education program! Join Our Community: Website : https://www.thepatientstory.com/ Facebook: @ThePatientStory Instagram: @ThePatientStory Twitter: @patient_story Contents of video: 00:00 Introduction 01:44 Immunotherapies and bispecifics in myeloma 09:58 Teclistamab 26:00 Treating with more than one bispecific antibody 31:44 Future of where bispecifics will be given 33:50 Treating high-risk patients with bispecifics #multiplemyeloma #multiplemyelomaawareness #bispecifics #CARTtherapy #CAR-T #cancer #MMSM #thepatientstory #myelomanews #myelomadrugs #cancerpatient